EU-Startups
French startup Exeliom Biosciences boosts funding with €2.85 million to accelerate immunotherapy for cancer
Paris-based Exeliom Biosciences, a clinical-stage BioTech company developing new therapies in immuno-oncology and immuno-inflammation, today announced the completion of a €2.85 million extension to its Series […]
